These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13587848)

  • 1. Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.
    NORMAN PS; HILL BM
    J Exp Med; 1958 Nov; 108(5):639-49. PubMed ID: 13587848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
    Aoki N; Moroi M; Matsuda M; Tachiya K
    J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of plasma protease inhibitors to antiplasmin activity in man.
    Crawford GP; Ogston D; Douglas AS
    Clin Sci Mol Med; 1976 Aug; 51(2):215-8. PubMed ID: 60190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measurement of human plasma antiplasmin activity by radial diffusion assay.
    Andes WA
    Thromb Haemost; 1978 Apr; 39(2):437-49. PubMed ID: 79230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin-heparin complex.
    Chang GMT; Atkinson HM; Berry LR; Chan AKC
    Blood Coagul Fibrinolysis; 2017 Sep; 28(6):431-437. PubMed ID: 27898513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood inhibitory capacity toward exogenous plasmin.
    Banbula A; Zimmerman TP; Novokhatny VV
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):241-6. PubMed ID: 17413760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of the inhibition of plasmin in acidified human plasma.
    Lijnen HR; Maes M; Castel M; Samama M; Collen D
    Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin-antiplasmin complex as a reservoir of fibrinolytic enzyme.
    AMBRUS CM; MARKUS G
    Am J Physiol; 1960 Sep; 199():491-4. PubMed ID: 13682944
    [No Abstract]   [Full Text] [Related]  

  • 10. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma inhibitors of the components of the fibrinolytic pathway in man.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1394-401. PubMed ID: 4122174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplasmin activity of electrophoretically separated human serum fractions.
    Mann RD; Cotton S; Jackson D
    J Clin Pathol; 1966 Mar; 19(2):185-9. PubMed ID: 4160096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antiplasmin and plasmin in rheumatoid arthritis.
    THOMAS DP; DINGLE JT
    Ann Rheum Dis; 1955 Jun; 14(2):195-7. PubMed ID: 14388598
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmin inactivation in plasma.
    Haselager EM; Goote TM; Vreeken J
    Thromb Haemost; 1976 Jun; 35(3):643-50. PubMed ID: 62411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.
    NORMAN PS
    J Exp Med; 1958 Jul; 108(1):53-68. PubMed ID: 13549641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a latex immunoturbidimetric assay for the automated measurement of alpha2 plasmin inhibitor-plasmin complex in human plasma.
    Fujimoto T; Nakamura K; Nishihira J
    Semin Thromb Hemost; 1999; 25(6):551-6. PubMed ID: 10632477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A solid-phase radioassay for the quantitative determination of antiplasmin activity in human plasma.
    Schmer G; Branson HE
    Br J Haematol; 1975 May; 30(1):117-22. PubMed ID: 127608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alpha2-plasmin inhibitor levels in liver diseases.
    Aoki N; Yamanaka T
    Clin Chim Acta; 1978 Mar; 84(1-2):99-105. PubMed ID: 76519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.